Literature DB >> 10209524

Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-beta) expression in the draining lymph nodes.

B S Lundin1, M R Karlsson, L A Svensson, L A Hanson, U I Dahlgren, E Telemo.   

Abstract

Adult rats were fed pellets containing ovalbumin (OvA) during 4 weeks, and were 2 weeks thereafter immunized subcutaneously with a mixture of OvA and human serum albumin (HSA) in Freund's complete adjuvant (day 0). As a result of the immunization, the draining lymph nodes of the nontolerized (control) rats were heavily enlarged from day 10 to day 18; however, this size increase was absent in the OvA-fed rats. This manifestation of active suppression in the tolerized rats was preceded by the appearance of scattered CD4+ TGF-beta-expressing T cells in the T cell area of their lymph nodes (days 5-8); correspondingly, the levels of TGF-beta mRNA in the nodes were elevated in the tolerant rats compared with the control rats. The anti-OvA antibody levels in sera from the rats revealed that there was an initial B cell priming in the OvA-fed group, with levels higher than in the control group during the first week. Thereafter, suppression governed the response, and from day 10 onwards the anti-OvA levels were considerably lower than in the controls. When other groups of animals were pretreated with neutralizing anti-TGF-beta antibodies 1 day before the immunization, the anti-OvA response of the OvA-fed rats was restored to the levels of the control group, demonstrating the importance of TGF-beta in the maintenance of suppression. In conclusion, we demonstrate that TGF-beta-producing cells appear in the draining lymph nodes shortly after immunization in rats made orally tolerant using a relatively high-dose feeding regime; these cells are probably responsible for the down-regulation of the immune response observed in the OvA-fed rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10209524      PMCID: PMC1905209          DOI: 10.1046/j.1365-2249.1999.00834.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Bystander suppression of the immune response to human serum albumin in rats fed ovalbumin.

Authors:  A Dahlman-Höglund; U Dahlgren; S Ahlstedt; L A Hanson; E Telemo
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

2.  Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.

Authors:  J D Gray; M Hirokawa; K Ohtsuka; D A Horwitz
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

3.  High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis.

Authors:  T Marth; W Strober; B L Kelsall
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

Review 4.  Oral tolerance: immune mechanisms and treatment of autoimmune diseases.

Authors:  H L Weiner
Journal:  Immunol Today       Date:  1997-07

5.  In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice.

Authors:  P A Gonnella; Y Chen; J Inobe; Y Komagata; M Quartulli; H L Weiner
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

6.  The induction of tolerance to a soluble protein antigen by oral administration.

Authors:  H C Thomas; M V Parrott
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

7.  TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia.

Authors:  K Haneda; K Sano; G Tamura; T Sato; S Habu; K Shirato
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

8.  Oral tolerization leads to active suppression and bystander tolerance in adult rats while anergy dominates in young rats.

Authors:  B S Lundin; U I Dahlgren; L A Hanson; E Telemo
Journal:  Scand J Immunol       Date:  1996-01       Impact factor: 3.487

9.  Inhibition of specific immune responses by feeding protein antigens.

Authors:  D G Hanson; N M Vaz; L C Maia; M M Hornbrook; J M Lynch; C A Roy
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

10.  A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.

Authors:  H Groux; A O'Garra; M Bigler; M Rouleau; S Antonenko; J E de Vries; M G Roncarolo
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

View more
  11 in total

1.  Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration.

Authors:  Susanne Hultkrantz; Sofia Ostman; Esbjörn Telemo
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

2.  Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.

Authors:  Annie George Chandy; Susanne Hultkrantz; Sukanya Raghavan; Cecil Czerkinsky; Michael Lebens; Esbjörn Telemo; Jan Holmgren
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

3.  Tolerance and bystander suppression, with involvement of CD25-positive cells, is induced in rats receiving serum from ovalbumin-fed donors.

Authors:  M R Karlsson; H Kahu; L A Hanson; E Telemo; U I Dahlgren
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

4.  Tolerosome-induced oral tolerance is MHC dependent.

Authors:  Sofia Ostman; Maria Taube; Esbjörn Telemo
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

5.  Parasite-mediated down-regulation of collagen-induced arthritis (CIA) in DA rats.

Authors:  L Mattsson; P Larsson; H Erlandsson-Harris; L Klareskog; R A Harris
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

6.  Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma.

Authors:  Nina Almqvist; Anna Lönnqvist; Susanne Hultkrantz; Carola Rask; Esbjörn Telemo
Journal:  Immunology       Date:  2008-03-19       Impact factor: 7.397

7.  The ratio of n-6 to n-3 fatty acids in maternal diet influences the induction of neonatal immunological tolerance to ovalbumin.

Authors:  M Korotkova; E Telemo; Y Yamashiro; L A Hanson; B Strandvik
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 8.  Mechanism of oral tolerance induction to therapeutic proteins.

Authors:  Xiaomei Wang; Alexandra Sherman; Gongxian Liao; Kam W Leong; Henry Daniell; Cox Terhorst; Roland W Herzog
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

9.  Stimulation of interleukin-10 production by acidic beta-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases.

Authors:  Guénolée Prioult; Sophie Pecquet; Ismail Fliss
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

10.  Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals.

Authors:  Anna Lundgren; Elisabeth Suri-Payer; Karin Enarsson; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.